Skip to main content
Fig. 5 | BMC Rheumatology

Fig. 5

From: Healthcare resource utilization and costs associated with inflammatory bowel disease among patients with chronic inflammatory diseases: a retrospective cohort study

Fig. 5

Comparison of costs during the 12-month observation period between patients developing versus not developing IBD. RA, rheumatoid arthritis; PsA, psoriatic arthritis; PsO, psoriasis; AS, ankylosing spondylitis; IBD, inflammatory bowel disease; MYCD, mean yearly cost difference; CI, confidence interval. * indicates that p-value < 0.05

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us